Avantax Advisory Services’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.61K Buy
+17,000
New +$5.61K ﹤0.01% 2357